Product Applications
———— late patet in sanos fructus ager;
--- Applicari in agro cibum et potum;
--- Applicata in stibio.
Effectus
1 .Facilisis operatio: Potest radicales liberas dissolvere et cellulas ab oxidative damno tueri.
2.Anti- inflammatione effectus: Inflammationem in corpore minuere adjuvat.
3.Tutela cardiovascularis: Sit habere positivum ictum in cor sanitatis reducendo sanguinem pressura et emendantem sanguinem lipidorum gradus.
4.Anticancer potentiale: Quaedam studia suadeant ut effectus inhibitores habere in quibusdam generibus cellulis carcinomatis.
5.Neuroprotective: Tueri neurons et beneficia potentiale ad sanitatem cerebri.
6.Anti-diabetic effectusProdesse posset moderari sanguinem saccharo campester.
Testimonium Analysis
| Product Name | Myricetin | Specification | Company Standard |
| OPIFICIUM Date | 2024.8.1 | Analysis Date | 2024.8.8 |
| Batch No. | BF-240801 | Exitus Date | 2026.7.31 |
| Items | Specifications | Proventus | |
| Ingrediatur per HPLC SIGMA vexillum | |||
| Myricetin | ≥80.0% | 81.6% | |
| Aspectus | Yellow ut viridi pulveris | Obsequitur | |
| Magnitudo particula | C% transeat LXXX mush | Obsequitur | |
| umor | ≤5.0% | 2.2% | |
| Metalla gravis | ≤20 ppm | Obsequitur | |
| As | ≤1 ppm | 0.02 | |
| Pb | ≤0.5 ppm | 0.15 | |
| Hg | ≤0.5 ppm | 0.01 | |
| Cd | ≤1 ppm | 0.12 | |
| Microbiologicum probat | |||
| Totalis comitis Plate | <1000cfu/g | <100cfu/g | |
| Fermentum et fingunt Comes | <100cfu /g | <10cfu /g | |
| E.Coli | Negative | Absens | |
| Salmonella | Negative | Absens | |
| Staphylococcus | Negative | Absens | |
| conclusio | Conformare cum qualitate vexillum | ||
| Repono | Condite in frigido & sicco place.Do non congelatur. Auferte a forti luce et calore. | ||
| Vita fasciae |
II annos cum bene condita | ||
Detail Image
